Literature DB >> 20937833

Long range interactions regulate Igf2 gene transcription during skeletal muscle differentiation.

Damir T Alzhanov1, Stephanie F McInerney, Peter Rotwein.   

Abstract

The differentiation, maintenance, and repair of skeletal muscle is controlled by interactions between genetically determined transcriptional programs regulated by myogenic transcription factors and environmental cues activated by growth factors and hormones. Signaling through the insulin-like growth factor 1 (IGF1) receptor by locally produced IGF2 defines one such pathway that is critical for normal muscle growth and for regeneration after injury. IGF2 gene and protein expression are induced as early events in muscle differentiation, but the responsible molecular mechanisms are unknown. Here we characterize a distal DNA element within the imprinted mouse Igf2-H19 locus with properties of a muscle transcriptional enhancer. We find that this region undergoes a transition to open chromatin during differentiation, whereas adjacent chromatin remains closed, and that it interacts in differentiating muscle nuclei but not in mesenchymal precursor cells with the Igf2 gene found more than 100 kb away, suggesting that chromatin looping or sliding to bring the enhancer in proximity to Igf2 promoters is also an early event in muscle differentiation. Because this element directly stimulates the transcriptional activity of an Igf2 promoter-reporter gene in differentiating myoblasts, our results indicate that we have identified a bona fide distal transcriptional enhancer that supports Igf2 gene activation in skeletal muscle cells. Because this DNA element is conserved in the human IGF2-H19 locus, our results further suggest that its muscle enhancer function also is conserved among different mammalian species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937833      PMCID: PMC2998108          DOI: 10.1074/jbc.M110.160986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation.

Authors:  Elizabeth M Wilson; Marlene M Hsieh; Peter Rotwein
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

2.  Location of enhancers is essential for the imprinting of H19 and Igf2 genes.

Authors:  A L Webber; R S Ingram; J M Levorse; S M Tilghman
Journal:  Nature       Date:  1998-02-12       Impact factor: 49.962

Review 3.  The MyoD family and myogenesis: redundancy, networks, and thresholds.

Authors:  H Weintraub
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

Review 4.  Wiring diagrams: regulatory circuits and the control of skeletal myogenesis.

Authors:  A Lassar; A Münsterberg
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

5.  Parental imprinting of the mouse H19 gene.

Authors:  M S Bartolomei; S Zemel; S M Tilghman
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

6.  The structural H19 gene is required for transgene imprinting.

Authors:  K Pfeifer; P A Leighton; S M Tilghman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation.

Authors:  C E Stewart; P L James; M E Fant; P Rotwein
Journal:  J Cell Physiol       Date:  1996-10       Impact factor: 6.384

8.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

9.  Transcriptional activation of the insulin-like growth factor-II gene during myoblast differentiation.

Authors:  K Kou; P Rotwein
Journal:  Mol Endocrinol       Date:  1993-02

10.  Disruption of imprinting caused by deletion of the H19 gene region in mice.

Authors:  P A Leighton; R S Ingram; J Eggenschwiler; A Efstratiadis; S M Tilghman
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

View more
  26 in total

1.  Akt-dependent anabolic activity of natural and synthetic brassinosteroids in rat skeletal muscle cells.

Authors:  Debora Esposito; Thirumurugan Rathinasabapathy; Alexander Poulev; Slavko Komarnytsky; Ilya Raskin
Journal:  J Med Chem       Date:  2011-05-26       Impact factor: 7.446

2.  Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1.

Authors:  Gia-Ming Hong; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2012-03-09       Impact factor: 4.219

Review 3.  The therapeutic potential of IGF-I in skeletal muscle repair.

Authors:  Yao-Hua Song; Jenny L Song; Patrice Delafontaine; Michael P Godard
Journal:  Trends Endocrinol Metab       Date:  2013-04-27       Impact factor: 12.015

4.  Defining human insulin-like growth factor I gene regulation.

Authors:  Aditi Mukherjee; Damir Alzhanov; Peter Rotwein
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-12       Impact factor: 4.310

5.  Organ-specific defects in insulin-like growth factor and insulin receptor signaling in late gestational asymmetric intrauterine growth restriction in Cited1 mutant mice.

Authors:  Tatiana Novitskaya; Mariana Baserga; Mark P de Caestecker
Journal:  Endocrinology       Date:  2011-04-12       Impact factor: 4.736

6.  TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II.

Authors:  Samantha Gardner; Damir Alzhanov; Paul Knollman; David Kuninger; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-11-24

7.  Identifying growth hormone-regulated enhancers in the Igf1 locus.

Authors:  Damir Alzhanov; Aditi Mukherjee; Peter Rotwein
Journal:  Physiol Genomics       Date:  2015-09-01       Impact factor: 3.107

8.  Myod and H19-Igf2 locus interactions are required for diaphragm formation in the mouse.

Authors:  Maud Borensztein; Paul Monnier; Franck Court; Yann Louault; Marie-Anne Ripoche; Laurent Tiret; Zizhen Yao; Stephen J Tapscott; Thierry Forné; Didier Montarras; Luisa Dandolo
Journal:  Development       Date:  2013-02-13       Impact factor: 6.868

9.  Characterizing a distal muscle enhancer in the mouse Igf2 locus.

Authors:  Damir Alzhanov; Peter Rotwein
Journal:  Physiol Genomics       Date:  2015-12-08       Impact factor: 3.107

10.  Insulin-like growth factor-II: new roles for an old actor.

Authors:  Stefano Cianfarani
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.